The Immune Globulin Subcutaneous Prefilled Syringe for PI and CIDP has been approved by the FDA for CSL Behring.

Published Date: 20 Apr 2023

The only immune globulin offered in prefilled syringes for patients with primary immunodeficiency or chronic inflammatory demyelinating polyneuropathy is CSL Behring's subcutaneous immune globulin.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The Boom in ADHD Coaching Has Few Rules

2.

Cancer patients with HIV have demonstrated safety with immune checkpoint inhibitors.

3.

The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.

4.

Medicaid expansion tied to smaller declines in early-stage cancer detection

5.

Specialist Referrals Are Critical for Functional High-Risk Multiple Myeloma


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot